Cite
HARVARD Citation
Gooderham, M. et al. (n.d.). THU0291 Incidence of serious gastrointestinal events and inflammatory bowel disease among tildrakizumab-treated patients with moderate to severe plaque psoriasis: data from 3 large randomised clinical trials. Annals of the rheumatic diseases. p. 364. [Online].